Cardiovascular prevention in HIV-positive individuals on antiretroviral therapy.. The paradigm shift has already happened: Is it time to wake up and realise it?

Abstract

Get full access to this article

View all access options for this article.

References

van Zoest R, van der Valk M and Wit F et al. Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy? Eur J Prev Cardiol. 2017; 24: 1297–1307.

Bloomfield

Alenezi

Barasa

et al.

Human immunodeficiency virus and heart failure in low- and middle-income countries. JACC Heart Fail 2015; 3: 579–590.

Freiberg

Chang

Kuller

et al.

HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013; 173: 614–622.

Nou

Grinspoon

. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS 2016; 30: 1495–1509.

Zanni

Toribio

Robbins

et al.

Effects of antiretroviral therapy on immune function and arterial inflammation in treatment-naive patients with human immunodeficiency virus infection. JAMA Cardiol 2016; 1: 474–480.

Lang

Mary-Krause

Cotte

et al.

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4. Arch Intern Med 2010; 170: 1228–1238.

Ryom L, Lundgren JD, El-Sadr W, et al. Association between cardiovascular disease and contemporarily used protease inhibitors. In: Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, WA, USA, 13–16 February 2017. San Francisco, CA: CROI.

Mikhail

Purdy

Dimock

et al.

High rate of coronary artery abnormalities in adolescents and young adults infected with human immunodeficiency virus early in life. Pediatr Infect Dis J 2011; 30: 710–712.

Coll

Parra

Alonso-Villaverde

et al.

The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection. Stroke 2007; 38: 2477–2484.

10.

Friis-Moller

Thiebaut

Reiss

et al.

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 2010; 17: 491–501.